NCT06469151 - A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of AZD5148 in Healthy Adults | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 24, 2024

Primary Completion Date

November 7, 2025

Study Completion Date

November 7, 2025

Conditions

Healthy Participants

Interventions

DRUG

AZD5148

Participants will receive AZD5148 (dose 1, dose 2, dose 3 or dose 4) as an IM injection or IV bolus

DRUG

Placebo

Participants will receive matching doses of placebo as an IM injection or IV bolus

Trial Locations (4)

Research Site, Baltimore

Research Site, Anniston

Research Site, San Antonio

Research Site, Glendale